Market Place
Sourcing Support
Veristat Appoints Gabriela Rosu, M.D., to Lead Growing Medical Affairs Team
29 May 2024 //
BUSINESSWIRE
Veristat Appoints New Chief Commercial Officer
23 May 2024 //
BUSINESSWIRE
Veristat Joins the ARM to Help Critical Issues Impacting Advanced Therapy Sector
03 Apr 2024 //
BUSINESSWIRE
Veristat acquires biometrics CRO Instat Clinical
24 Oct 2023 //
FIERCE BIOTECH
Veristat Acquires Biometrics-focused Instat Clinical Research
19 Oct 2023 //
BUSINESSWIRE
Veristat Acquires European Medical Writing Consultancy Scinopsis
12 Jun 2023 //
BUSINESSWIRE
Veristat Taps Accomplished Industry Leaders to Support Growth and Innovation
23 May 2023 //
BUSINESSWIRE
Veristat Congratulates HIPRA for EMA Approval of Its BIMERVAX® COVID-19 Vaccine
25 Apr 2023 //
BUSINESSWIRE
Veristat Supported Eight Regulatory Approvals in 2022
14 Feb 2023 //
BUSINESSWIRE
Veristat Presents Integrated, Customized DCT Solutions at DTRA Annual Meeting
13 Dec 2022 //
BUSINESSWIRE
Veristat Joins DTRA to Improve the Patient Experience
13 Oct 2022 //
BUSINESSWIRE
Veristat Launches Strategic Resourcing to Build Greater Flexibility
29 Mar 2022 //
BUSINESSWIRE
Veristat Expands its Expertise and Scale across Biopharma and Medtech
07 Mar 2022 //
BUSINESSWIRE
Veristat Appoints Joe Scott as Chief Financial Officer
23 Feb 2022 //
BUSINESSWIRE
Veristat Supported Marketing Applications for 12% of FDA Novel Drug Approvals
11 Jan 2022 //
BUSINESSWIRE
Veristat Strengthens Regulatory Capabilities Across Europe and UK
11 Nov 2021 //
BUSINESSWIRE
Verista Partners With INCOG BioPharma Services
08 Jun 2021 //
PRNEWSWIRE
Veristat Announces Global Cell and Gene Therapy Center of Excellence
21 Oct 2020 //
OAOA
Veristat Enhances Patient-Centricity Offering by Delivering Clinical Trials
30 Sep 2020 //
BUSINESSWIRE
Veristat Enhances Patient-Centricity Offering by Delivering Clinical Trials
29 Sep 2020 //
BUSINESSWIRE
Veristat Strengthens Its European Presence with The Clinical Trial Company
07 Jan 2020 //
BUSINESS WIRE
Veristat Congratulates TESARO on the FDA Approval of ZEJULA™
30 May 2017 //
PRESS RELEASE
Veristat Acknowledged on Boston Business Journal’s “Fast 50” List
15 May 2017 //
PRESS RELEASE
Veristat Formalizes its Strategic Decision Consulting Services
01 Nov 2016 //
PRESS RELEASE
Veristat Strengthens Its Long-Standing Relationship with Aegerion Pharma
20 Sep 2016 //
PRESS RELEASE
Veristat Acknowledged for its Rapid Growth
17 Aug 2016 //
PRESS RELEASE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.